On November 21, 2019 Can-Fite BioPharma Ltd. (NYSE American: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, reported its CEO Pnina Fishman Ph.D. will share insight into the Company’s recent developments during an investor webinar on Monday, November 25, 2019 at 11:00 a.m. ET (Press release, Can-Fite BioPharma, NOV 21, 2019, View Source [SID1234551589]). A live Q&A session with Dr. Fishman will follow her presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To join the Can-Fite webinar, please register via the following link: View Source

The webinar will be accessible through the News/Events section of Can-Fite’s website at www.canfite.com, where it will also be archived for a period of time.

Questions can be pre-submitted to [email protected] or during the event.